SUNDAY Trial

47 posts

SUNDAY Trial banner
SUNDAY Trial

SUNDAY Trial

@SUNDAYtrial

The SUNDAY trial is a RCT addressing the impact of TEVAR on 5 year mortality among patients with uTBAD

Entrou em Haziran 2024
228 Seguindo58 Seguidores
SUNDAY Trial retweetou
Timo T Soderlund
Timo T Soderlund@ADsept19·
Try this prompt with #Grok3: ""Provide me with an extensive global news roundup the past 2 days. Source updates from major media outlets and trends across at least four languages (English, Chinese, Spanish, Arabic) and multiple countries, reflecting what people worldwide are waking up to. Keep it unbiased, fact-based, and concise, covering geopolitics, economics, technology, and societal issues. Highlight regional variations in focus or perspective where relevant. Deliver it like a morning coffee briefing—no commentary, just the news.""
Timo T Soderlund tweet media
English
1
1
1
251
Firas F Mussa
Firas F Mussa@UnTBAD·
IMPROVE-AD: 56/60 sites active with @usc_vascular #1 enrolling site. Who can top them?! @VascularSVS For uTBAD (HRF or not): enrolling in the trial is the BEST CARE ANYWHERE!
English
2
2
7
519
SUNDAY Trial retweetou
Firas F Mussa
Firas F Mussa@UnTBAD·
With <100 patients ever followed for 5 years and $0 spent in funding, IMPROVE-AD is the only chance to ask and answer almost ALL the remaining questions in uTBAD! Same for @SUNDAYtrial @VascularSVS
Firas F Mussa tweet media
English
1
3
7
515
Matthew Smeds
Matthew Smeds@mattsmeds·
I’ve played around on the new @VascularSVS patient info portal (Your Vascular Health)… great info for patients about many vascular conditions. Amazing resource I’ll share with my patients. vascular.org/your-vascular-…
English
3
2
15
1.5K